IL307508A - Mammalian dendritic cell hyperactivators - Google Patents

Mammalian dendritic cell hyperactivators

Info

Publication number
IL307508A
IL307508A IL307508A IL30750823A IL307508A IL 307508 A IL307508 A IL 307508A IL 307508 A IL307508 A IL 307508A IL 30750823 A IL30750823 A IL 30750823A IL 307508 A IL307508 A IL 307508A
Authority
IL
Israel
Prior art keywords
hyperactivators
dendritic cells
mammalian dendritic
mammalian
cells
Prior art date
Application number
IL307508A
Other languages
English (en)
Hebrew (he)
Inventor
Kelsey K Finn
Jonathan Chow
Emily Gosselin
Dania Zhivaki
Original Assignee
Corner Therapeutics Inc
Kelsey K Finn
Jonathan Chow
Emily Gosselin
Dania Zhivaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corner Therapeutics Inc, Kelsey K Finn, Jonathan Chow, Emily Gosselin, Dania Zhivaki filed Critical Corner Therapeutics Inc
Publication of IL307508A publication Critical patent/IL307508A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL307508A 2021-04-12 2022-04-11 Mammalian dendritic cell hyperactivators IL307508A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163173958P 2021-04-12 2021-04-12
US202163246740P 2021-09-21 2021-09-21
PCT/US2022/071664 WO2022221827A2 (en) 2021-04-12 2022-04-11 Hyperactivators of mammalian dendritic cells

Publications (1)

Publication Number Publication Date
IL307508A true IL307508A (en) 2023-12-01

Family

ID=81749254

Family Applications (1)

Application Number Title Priority Date Filing Date
IL307508A IL307508A (en) 2021-04-12 2022-04-11 Mammalian dendritic cell hyperactivators

Country Status (7)

Country Link
US (1) US20240197869A1 (cg-RX-API-DMAC7.html)
EP (1) EP4322999A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024514026A (cg-RX-API-DMAC7.html)
AU (1) AU2022257111A1 (cg-RX-API-DMAC7.html)
CA (1) CA3215072A1 (cg-RX-API-DMAC7.html)
IL (1) IL307508A (cg-RX-API-DMAC7.html)
WO (1) WO2022221827A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4475824A1 (en) * 2022-02-07 2024-12-18 Corner Therapeutics, Inc. Immunogenic mrna delivery vehicles
US20250127868A1 (en) * 2022-02-07 2025-04-24 Corner Therapeutics, Inc. Hyperactivating lipid nanoparticles
EP4654955A2 (en) * 2023-01-27 2025-12-03 Corner Therapeutics, Inc. Phospholipid analogs for hyperactivation of mammalian dendritic cells
WO2024192034A2 (en) * 2023-03-13 2024-09-19 Corner Therapeutics, Inc. Bystander antigen enhancement of tumor cell lysate immunogenicity
WO2025221606A1 (en) * 2024-04-16 2025-10-23 Corner Therapeutics, Inc. Lipids for hyperactivation of mammalian dendritic cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2836829B1 (fr) * 2002-03-11 2005-11-25 Bio Merieux Utilisation de l-alpha-lysophosphatidylcholine pour obtenir la differenciation de monocytes en cellules dendritiques matures in vitro
FR2836828A1 (fr) * 2002-03-11 2003-09-12 Bio Merieux Utilisation de l-alpha-lysophosphatidylcholine pour obtenir la differenciation de monocytes en cellules dendritiques matures in vitro
WO2004091603A1 (fr) * 2003-04-07 2004-10-28 Clinigenetics Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
CN102293743B (zh) * 2010-06-24 2013-09-18 辽宁成大生物股份有限公司 一种脂质微球组合物
KR101951933B1 (ko) * 2013-03-12 2019-02-25 주식회사 아리바이오 라이소포스파티딜콜린 또는 이의 유도체를 포함하는 지질나노물질 및 이의 제조방법

Also Published As

Publication number Publication date
WO2022221827A3 (en) 2022-12-29
EP4322999A2 (en) 2024-02-21
US20240197869A1 (en) 2024-06-20
WO2022221827A2 (en) 2022-10-20
JP2024514026A (ja) 2024-03-27
CA3215072A1 (en) 2022-10-20
AU2022257111A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
IL307501A (en) Modified mammalian cells
IL277025A (en) Methods for improving the differentiation of stem cells into beta cells
MX2019000180A (es) Composiciones de células t para la inmunoterapia.
ZA201104931B (en) Bioreactor for the cultivation of mammalian cells
WO2012064606A3 (en) Tissue-specific extracellular matrix with or without tissue protein components for cell culture
EP2551341A4 (en) CULTURE METHOD FOR CREATING THE DIFFERENTIATION OF PLURIPOTENTAL MAMMALIAN CELLS
IL304349A (en) Cell culture methods
IL279535A (en) Production of transgenic dendritic cells and their uses
IL291074A (en) Methods for preparing t cells for t cell therapy
IL299288A (en) Transfection of mRNA in immune cells
SG11202113311XA (en) Method of identifying pro-inflammatory dendritic cells
EP2616073A4 (en) INHIBITORS OF IMMERSION OF VIRUSES IN MAMMALIAN HOST CELLS
IL287562A (en) Methods of manufacturing allogeneic car t cells
PL3652292T3 (pl) Naczynie do hodowli komórkowej 3d i sposoby hodowli komórkowej 3d
EP3270934A4 (en) Microcarriers, matrices and scaffolds for culturing mammalian cells and methods of manufacture
MX2010007945A (es) Preparacion y transplante de celulas de isletas pancreaticas.
IL216368A0 (en) Method for determininig the cardio-generative potential of mammalian cells
IL288301B1 (en) Methods for culturing pluripotent stem cells
GB201815189D0 (en) Method of cooling battery cells
HK40107084A (en) Hyperactivators of mammalian dendritic cells
ZA202101139B (en) Culturing of stem cells
IL292451B2 (en) Electrode for electrochemical evolution of hydrogen
IL320085A (en) B cell lineages derived from pluripotent cells
IL320075A (en) Natural killer cell lineages derived from pluripotent cells
EP4349967A4 (en) NEW PLURIPOTENT CELLS